✦ LIBER ✦

An Alternate Pathway for CD4 T Cell Development: Thymocyte-Expressed MHC Class II Selects a Distinct T Cell Population

✍ Scribed by Wei Li; Moon-Gyo Kim; Tania S. Gourley; Brian P. McCarthy; Derek B. Sant’Angelo; Cheong-Hee Chang

Book ID: 116570495
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 623 KB
Volume: 23
Category: Article
ISSN: 1074-7613
DOI: 10.1016/j.immuni.2005.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective development of CD4+ T cells in

Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor

✍ Kaye, Jonathan; Hsu, Mei-Ling; Sauron, Marie-Elizabeth; Jameson, Stephen C.; Gas 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 421 KB

Peptide-antibody conjugates for tumour t

Peptide-antibody conjugates for tumour therapy: A MHC-class-II-restricted tetanus toxin peptide coupled to an anti-IG light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells

✍ Zhiwei Yu; Frank Healy; Danila Valmori; Patricia Escobar; Giampietro Corradin; J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 729 KB

Anti-idiotype antibody therapy of B-cell lymphomas, despite numerous promising experimental and clinical studies, has so far met with limited success. Tailor-made monoclonal antiidiotype antibodies have been injected into a large series of lymphoma patients, with a few impressive complete tumour rem